annual EBITDA:
-$396.44M+$723.62M(+64.61%)Summary
- As of today (June 22, 2025), ONC annual EBITDA is -$396.44 million, with the most recent change of +$723.62 million (+64.61%) on December 31, 2024.
- During the last 3 years, ONC annual EBITDA has risen by +$995.84 million (+71.53%).
- ONC annual EBITDA is now -12497.30% below its all-time high of -$3.15 million, reached on December 1, 2013.
Performance
ONC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$43.91M+$73.08M(+250.47%)Summary
- As of today (June 22, 2025), ONC quarterly EBITDA is $43.91 million, with the most recent change of +$73.08 million (+250.47%) on March 1, 2025.
- Over the past year, ONC quarterly EBITDA has increased by +$279.96 million (+118.60%).
- ONC quarterly EBITDA is now -62.22% below its all-time high of $116.20 million, reached on September 1, 2017.
Performance
ONC quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$116.48M+$279.96M(+70.62%)Summary
- As of today (June 22, 2025), ONC TTM EBITDA is -$116.48 million, with the most recent change of +$279.96 million (+70.62%) on March 1, 2025.
- Over the past year, ONC TTM EBITDA has increased by +$888.39 million (+88.41%).
- ONC TTM EBITDA is now -1373.63% below its all-time high of -$7.90 million, reached on September 1, 2014.
Performance
ONC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ONC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.6% | +118.6% | +88.4% |
| 3 y3 years | +71.5% | +110.3% | +93.9% |
| 5 y5 years | +57.9% | +112.0% | +91.7% |
ONC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +77.0% | at high | +109.7% | at high | +93.7% |
| 5 y | 5-year | at high | +77.0% | -45.0% | +107.9% | at high | +93.9% |
| alltime | all time | <-9999.0% | +77.0% | -62.2% | +107.9% | -1373.6% | +93.9% |
ONC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $43.91M(-250.5%) | -$116.48M(-70.6%) |
| Dec 2024 | -$396.44M(-64.6%) | -$29.18M(-40.4%) | -$396.44M(-45.5%) |
| Sep 2024 | - | -$48.97M(-40.4%) | -$727.23M(-8.0%) |
| Jun 2024 | - | -$82.23M(-65.2%) | -$790.72M(-21.3%) |
| Mar 2024 | - | -$236.06M(-34.4%) | -$1.00B(-10.3%) |
| Dec 2023 | -$1.12B(-35.0%) | -$359.98M(+220.1%) | -$1.12B(-7.5%) |
| Sep 2023 | - | -$112.46M(-62.1%) | -$1.21B(-20.4%) |
| Jun 2023 | - | -$296.38M(-15.6%) | -$1.52B(-7.7%) |
| Mar 2023 | - | -$351.25M(-22.1%) | -$1.65B(-4.4%) |
| Dec 2022 | -$1.72B(+23.8%) | - | - |
| Dec 2022 | - | -$450.61M(+6.7%) | -$1.72B(-5.9%) |
| Sep 2022 | - | -$422.16M(-0.4%) | -$1.83B(-1.5%) |
| Jun 2022 | - | -$423.94M(-0.6%) | -$1.86B(-2.1%) |
| Mar 2022 | - | -$426.69M(-23.6%) | -$1.90B(+36.4%) |
| Dec 2021 | -$1.39B(-14.4%) | -$558.62M(+24.1%) | -$1.39B(+6.2%) |
| Sep 2021 | - | -$450.15M(-2.8%) | -$1.31B(+1.4%) |
| Jun 2021 | - | -$463.31M(-680.6%) | -$1.29B(+9.5%) |
| Mar 2021 | - | $79.80M(-116.7%) | -$1.18B(-27.4%) |
| Dec 2020 | -$1.63B(+72.7%) | -$477.08M(+10.5%) | -$1.63B(+6.3%) |
| Sep 2020 | - | -$431.79M(+23.0%) | -$1.53B(+8.8%) |
| Jun 2020 | - | -$351.01M(-4.1%) | -$1.41B(+23.6%) |
| Mar 2020 | - | -$366.01M(-3.8%) | -$1.14B(+20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$941.27M(+35.4%) | -$380.55M(+23.5%) | -$941.27M(+12.3%) |
| Sep 2019 | - | -$308.24M(+275.3%) | -$838.17M(+23.5%) |
| Jun 2019 | - | -$82.14M(-51.8%) | -$678.58M(-10.4%) |
| Mar 2019 | - | -$170.34M(-38.6%) | -$757.15M(+8.9%) |
| Dec 2018 | -$695.38M(+642.1%) | -$277.44M(+86.6%) | -$695.38M(+33.8%) |
| Sep 2018 | - | -$148.66M(-7.5%) | -$519.68M(+103.9%) |
| Jun 2018 | - | -$160.71M(+48.0%) | -$254.82M(+68.1%) |
| Mar 2018 | - | -$108.56M(+6.7%) | -$151.59M(+61.8%) |
| Dec 2017 | -$93.70M(-18.6%) | -$101.74M(-187.6%) | -$93.70M(+225.9%) |
| Sep 2017 | - | $116.20M(-302.2%) | -$28.75M(-84.0%) |
| Jun 2017 | - | -$57.48M(+13.4%) | -$179.28M(+22.9%) |
| Mar 2017 | - | -$50.68M(+37.7%) | -$145.93M(+26.7%) |
| Dec 2016 | -$115.15M(+108.6%) | -$36.80M(+7.2%) | -$115.15M(+9.0%) |
| Sep 2016 | - | -$34.32M(+42.2%) | -$105.67M(+24.8%) |
| Jun 2016 | - | -$24.14M(+21.3%) | -$84.64M(+29.2%) |
| Mar 2016 | - | -$19.89M(-27.2%) | -$65.50M(+18.7%) |
| Dec 2015 | -$55.20M(+288.7%) | -$27.32M(+105.4%) | -$55.20M(+74.1%) |
| Sep 2015 | - | -$13.30M(+166.2%) | -$31.70M(+20.5%) |
| Jun 2015 | - | -$5.00M(-47.9%) | -$26.31M(+23.4%) |
| Mar 2015 | - | -$9.59M(+151.5%) | -$21.31M(+81.9%) |
| Dec 2014 | -$14.20M(+351.2%) | -$3.81M(-51.7%) | -$11.72M(+48.3%) |
| Sep 2014 | - | -$7.90M | -$7.90M |
| Dec 2013 | -$3.15M | - | - |
FAQ
- What is BeOne Medicines annual EBITDA?
- What is the all time high annual EBITDA for BeOne Medicines?
- What is BeOne Medicines annual EBITDA year-on-year change?
- What is BeOne Medicines quarterly EBITDA?
- What is the all time high quarterly EBITDA for BeOne Medicines?
- What is BeOne Medicines quarterly EBITDA year-on-year change?
- What is BeOne Medicines TTM EBITDA?
- What is the all time high TTM EBITDA for BeOne Medicines?
- What is BeOne Medicines TTM EBITDA year-on-year change?
What is BeOne Medicines annual EBITDA?
The current annual EBITDA of ONC is -$396.44M
What is the all time high annual EBITDA for BeOne Medicines?
BeOne Medicines all-time high annual EBITDA is -$3.15M
What is BeOne Medicines annual EBITDA year-on-year change?
Over the past year, ONC annual EBITDA has changed by +$723.62M (+64.61%)
What is BeOne Medicines quarterly EBITDA?
The current quarterly EBITDA of ONC is $43.91M
What is the all time high quarterly EBITDA for BeOne Medicines?
BeOne Medicines all-time high quarterly EBITDA is $116.20M
What is BeOne Medicines quarterly EBITDA year-on-year change?
Over the past year, ONC quarterly EBITDA has changed by +$279.96M (+118.60%)
What is BeOne Medicines TTM EBITDA?
The current TTM EBITDA of ONC is -$116.48M
What is the all time high TTM EBITDA for BeOne Medicines?
BeOne Medicines all-time high TTM EBITDA is -$7.90M
What is BeOne Medicines TTM EBITDA year-on-year change?
Over the past year, ONC TTM EBITDA has changed by +$888.39M (+88.41%)